Loading clinical trials...
Loading clinical trials...
The investigators will assess the prediction performance of the modified Surprise Question (Will the participant be surprised if this patient transfers to hemodialysis in the next 6 months?) for identification of peritoneal dialysis at high risk of transfer to hemodialysis. The investigators will also assess the prediction performance of a modified mortality surprise question (Will the participant be surprised if this patient dies in the next 6 months?).
Physicians and nurses will be asked two questions regarding each of their peritoneal dialysis patients: 1. Will the participant be surprised if this patient transfers to hemodialysis in the next 6 months? 2. Will the participant be surprised if this patient dies in the next 6 months? Patients will be followed for 6 months for outcomes (with two extra months for ascertainment of outcomes).
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Satellite Healthcare Inc
San Jose, California, United States
Start Date
November 20, 2020
Primary Completion Date
May 30, 2021
Completion Date
July 20, 2022
Last Updated
July 26, 2022
2,019
ACTUAL participants
no intervention
OTHER
Lead Sponsor
Satellite Healthcare
NCT06884280
NCT07271420
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions